Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 36, 1981 - Issue 3
2
Views
0
CrossRef citations to date
0
Altmetric
Case report

A Three Year Follow-Up Study of a Patient With a Malignant Islet Cell Tumour Treated With Streptozotocin

, &
Pages 150-154 | Published online: 17 May 2016

References

  • Bhuyan BK. The action of Streptozotocin on mammalian cells. Cancer Res. 1970; 30: 2017 23.
  • Carter SK, Broder LE. The cytostatic therapy of hormone-secreting tumors of the GI tract. Clin in Gastroenterol. 1974; 3: 733–45.
  • Handelsman H., Broder LE, Slavik M, Carter SK. Streptozotocin-NSC-85998-Clinical brochure. National Cancer Institute.
  • Murray-Lyon IM, Eddleston ALWF, Williams R et al. Treatment of multiple-hormoneproducing malignant islet-cell tumor with Streptozotocin. Lancet. 1968; ii: 895–8.
  • Broder LE, Carter SK. Pancreatic islet cell carcinoma. II. Results of therapy with Streptozotocin in 52 patients. Ann Intern Med. 1973; 79: 108–18.
  • Editorial. Streptozotocin for islet cell carcinoma. Lancet. 1973; ii: 1063–4.
  • Schein PS, Kahn RC, Gorden P. Wells S, DeVita VT. Streptozotocin for malignant insulinomas and carcinoid tumor. Arch Int Med. 1973; 132: 555–61.
  • Schreibman PH, Goransky de Koliren L, Arky RA. Metastatic insulinoma treated with Streptozotocin. Ann Intern Med. 1971; 74: 399–403.
  • Kiang DT, Frenning DH, Bauer GE. Mithramycin for hypoglycemia in malignant insulinoma. N Engl J Med. 1978; 299: 134–5.
  • Eastman RC, Come SE, Strewler GJ, Gorden P, Kahn CR. Adriamycin therapy for advanced insulinoma. J Clin Endocrinol Metab. 1977; 44: 142–8.
  • Schein PS. Chemotherapeutic management of the hormone-secreting endocrine malignancies. Cancer. 1972; 30: 1616–26.
  • Vavra J.I, Deboer C, Dietz A, Hanka LJ, Sokolski WT. Streptozotocin, a new antibacterial antibiotic. Antibiot Annu. 1959–60; 7: 230–5.
  • Sadoff L. Effects of Streptozotocin in a patient with islet cell carcinoma. Diabetes. 1969; 18: 675–8.
  • Smilh CK, Stoll RW, Vance J, Ricketts H, Williams RH. Treatment of malignant insulinoma with Streptozotocin. Diabetologica. 1971; 7: 118–24.
  • Moertel CG, Douglas Jr HO, Hanley J, Carbone PP. Treatment of advanced adenocarcinoma of the pancreas with combinations of Streptozotocin plus 5-Fluorouracil and Streptozotocin plus Cyclo-phosphamide. Cancer. 1977; 40: 605–8.
  • Moertel CG, Hanley J, Johnson LA. Streptozotocin alone compared with Streptozotocin plus Fluorouracil in the treatment of advanced islet-cell carcinoma. N Engl J Med. 1980; 303: 1189–94.
  • Beylot J, Veyret V, Vallat I, Longy M, Moretti G. Streptozotocine et insulinomes malins. Sem Hop Paris. 1976; 52, 489–96.
  • Haemers S. Een patient met insulinoma. Tijdschr Geneesk. 1980; 36: 761–4.
  • Sadoff L. Nephrotoxicity of Streptozotocin. Cancer Chemother Rep. 1970; 54: 457–9.
  • Schein PS, DeLellis RA, Kahn CR, GordenP, Kraft AR. Islet cell tumors: current concepts and management. Ann Intern Med. 1973; 79: 239–57.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.